WallStreetZenWallStreetZen

NASDAQ: VNDA
Vanda Pharmaceuticals Inc Stock Ownership - Who owns Vanda Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Vanda Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Gunther BirznieksSVP Business Development2026-03-0242,431$8.27
$350.73kSell
Kevin Patrick MoranSVP CFO Treasurer2026-03-0242,442$8.27
$350.83kSell
Mihael Hristos PolymeropoulosPresident and CEO2026-03-02156,235$8.17
$1.28MSell
Joakim WijkstromSVP Chief Marketing Officer2026-03-0230,800$8.27
$254.59kSell
Timothy WilliamsSVP General Counsel2026-03-0242,434$8.27
$350.76kSell
Tage HonoreDirector2026-02-2330,000$8.03
$240.90kSell

1 of 1

VNDA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VNDA insiders and whales buy or sell their stock.

VNDA Shareholders

What type of owners hold Vanda Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
James E. Flynn14.34%8,669,076$43.78MInsider
Kevin C. Tang4.49%2,715,852$13.72MInsider
Mihael Hristos Polymeropoulos4.47%2,704,496$13.66MInsider
Rho Ventures IV LP4.16%2,518,177$12.72MInsider
James C. Blair3.30%1,995,976$10.08MInsider
Robert J. More3.30%1,995,976$10.08MInsider
Kathleen K. Schoemaker3.30%1,995,976$10.08MInsider
Jesse I. Treu3.30%1,995,976$10.08MInsider
Nicole Vitullo3.30%1,995,976$10.08MInsider
Brian H. Dovey3.30%1,995,976$10.08MInsider

1 of 3

VNDA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VNDA0.08%69.36%Net Selling
EVMN0.10%58.21%Net BuyingNet Buying
IPSC0.09%23.43%Net SellingNet Selling
ABEO0.07%75.06%Net SellingNet Selling
PRLD0.06%51.13%Net Buying
View Top Biotech Stocks

Vanda Pharmaceuticals Stock Ownership FAQ

Who owns Vanda Pharmaceuticals?

Vanda Pharmaceuticals (NASDAQ: VNDA) is owned by 0.08% institutional shareholders, 69.36% Vanda Pharmaceuticals insiders, and 30.56% retail investors. James E. Flynn is the largest individual Vanda Pharmaceuticals shareholder, owning 8.67M shares representing 14.34% of the company. James E. Flynn's Vanda Pharmaceuticals shares are currently valued at $43.78M.

If you're new to stock investing, here's how to buy Vanda Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.